Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2014 1
2015 2
2016 4
2017 2
2018 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer.
Birge RB, Boeltz S, Kumar S, Carlson J, Wanderley J, Calianese D, Barcinski M, Brekken RA, Huang X, Hutchins JT, Freimark B, Empig C, Mercer J, Schroit AJ, Schett G, Herrmann M. Birge RB, et al. Cell Death Differ. 2016 Jun;23(6):962-78. doi: 10.1038/cdd.2016.11. Epub 2016 Feb 26. Cell Death Differ. 2016. PMID: 26915293 Free PMC article. Review.
MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity.
Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I. Cai B, et al. Sci Signal. 2018 Sep 25;11(549):eaar3721. doi: 10.1126/scisignal.aar3721. Sci Signal. 2018. PMID: 30254055 Free PMC article.
Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment.
Kumar S, Calianese D, Birge RB. Kumar S, et al. Immunol Rev. 2017 Nov;280(1):149-164. doi: 10.1111/imr.12587. Immunol Rev. 2017. PMID: 29027226 Review.
TAM receptors in apoptotic cell clearance, autoimmunity, and cancer.
Nguyen KQ, Tsou WI, Kotenko S, Birge RB. Nguyen KQ, et al. Autoimmunity. 2013 Aug;46(5):294-7. doi: 10.3109/08916934.2013.794515. Epub 2013 May 10. Autoimmunity. 2013. PMID: 23662598 Review.
Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer.
Knott ME, Minatta JN, Roulet L, Gueglio G, Pasik L, Ranuncolo SM, Nuñez M, Puricelli L, De Lorenzo MS. Knott ME, et al. J Mol Biomark Diagn. 2016 Jun;1(Suppl 2):015. doi: 10.4172/2155-9929.S2-015. Epub 2016 May 20. J Mol Biomark Diagn. 2016. PMID: 27358750 Free PMC article.
Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.
Kimani SG, Kumar S, Davra V, Chang YJ, Kasikara C, Geng K, Tsou WI, Wang S, Hoque M, Boháč A, Lewis-Antes A, De Lorenzo MS, Kotenko SV, Birge RB. Kimani SG, et al. Cell Commun Signal. 2016 Sep 6;14(1):19. doi: 10.1186/s12964-016-0142-1. Cell Commun Signal. 2016. PMID: 27595981 Free PMC article.
Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway.
Saleh T, Jankowski W, Sriram G, Rossi P, Shah S, Lee KB, Cruz LA, Rodriguez AJ, Birge RB, Kalodimos CG. Saleh T, et al. Nat Chem Biol. 2016 Feb;12(2):117-23. doi: 10.1038/nchembio.1981. Epub 2015 Dec 14. Nat Chem Biol. 2016. PMID: 26656091 Free PMC article.
Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
Sriram G, Jankowski W, Kasikara C, Reichman C, Saleh T, Nguyen KQ, Li J, Hornbeck P, Machida K, Liu T, Li H, Kalodimos CG, Birge RB. Sriram G, et al. Oncogene. 2015 Aug 6;34(32):4260-9. doi: 10.1038/onc.2014.361. Epub 2014 Nov 10. Oncogene. 2015. PMID: 25381819 Free PMC article.
Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.
Geng K, Kumar S, Kimani SG, Kholodovych V, Kasikara C, Mizuno K, Sandiford O, Rameshwar P, Kotenko SV, Birge RB. Geng K, et al. Front Immunol. 2017 Nov 10;8:1521. doi: 10.3389/fimmu.2017.01521. eCollection 2017. Front Immunol. 2017. PMID: 29176978 Free PMC article.
Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton.
Hossain S, Dubielecka PM, Sikorski AF, Birge RB, Kotula L. Hossain S, et al. Genes Cancer. 2012 May;3(5-6):402-13. doi: 10.1177/1947601912460051. Genes Cancer. 2012. PMID: 23226578 Free PMC article.
11 results
Jump to page